MEDIOCON INC – Ketazocine is a synthetic benzomorphan derivative and opioid-receptor ligand that has been extensively studied in pharmacological research, particularly for its activity at the κ-opioid receptor. It is also known by the research designation WIN-34276 and the synonym ketocyclazocine.
Ketazocine is a structurally complex opioid-related compound containing a benzomorphan framework. It has been used primarily as a pharmacological research compound for studying opioid receptor subtypes, receptor selectivity and mechanisms of opioid-mediated biological activity.
PubChem identifies Ketazocine as a small molecule with Phase 2 maximum development status in ChEMBL data, while NCATS identifies it as an INN/USAN substance.
Product Name: Ketazocine
CAS Number: 36292-69-0
Molecular Formula: C₁₈H₂₃NO₂
Molecular Weight: 285.40 g/mol
Chemical Class: Benzomorphan derivative
Pharmacological Class: Opioid receptor ligand / κ-opioid receptor research compound
Development / Research Code: WIN-34276 / WIN 34,276
Synonyms: Ketocyclazocine, Ketazocina, Ketazocinum
PubChem CID: 3054741
The CAS number, molecular formula and molecular weight are reported by PubChem and the NIH/NCATS substance database.
Ketazocine is associated with opioid receptor activity, particularly at the κ-opioid receptor. It has been used as a pharmacological tool for investigating opioid receptor subtypes and their physiological and behavioral effects.
Its receptor activity makes Ketazocine useful in experimental studies involving opioid pharmacology, analgesia, receptor selectivity and central nervous system mechanisms.
MEDIOCON INC focuses on supplying pharmaceutical and specialty research compounds with emphasis on quality, consistency, technical documentation and reliable supply.
Ketazocine quality evaluation may include:
The exact acceptance criteria should be confirmed against the current approved specification and batch-specific Certificate of Analysis.
Ketazocine may be used for:
A reliable current commercial specification for the physical appearance of Ketazocine free base could not be verified from authoritative sources.
Appearance: Not reliably available / Cannot be verified
For a commercial product page, the exact appearance should be taken from the applicable MEDIOCON INC specification or batch COA rather than using an assumed description.
Product availability, packaging configuration, Certificate of Analysis (COA), Safety Data Sheet (SDS/MSDS), analytical data and technical specifications should be confirmed with MEDIOCON INC according to the intended research application.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Ketazocine API Manufacturer and Supplier in India (CAS 36292-69-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Ketazocine API Manufacturer and Supplier in India is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance